Phase I tolerability, pharmacokinetics and preliminary efficacy of ACH 1625 in volunteers and hepatitis C-infected patients
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 03 Apr 2011
At a glance
- Drugs Sovaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 03 Apr 2011 Results presented at the 46th Annual Meeting of the European Association for the Study of the Liver.
- 15 Sep 2010 An abstract has been accepted as a late-breaking poster at the 61st Annual Meeting of the American Association for the Study of Liver Disease (AASLD), according to an Achillion Pharmaceuticals media release.
- 11 May 2010 Additional preliminary results from the phase 1b part of the trial have been reported in a Achillion Pharmaceuticals media release.